关注
Paula Cannon
Paula Cannon
未知所在单位机构
在 usc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
A transient three-plasmid expression system for the production of high titer retroviral vectors
Y Soneoka, PM Cannon, EE Ramsdale, JC Griffiths, G Romano, ...
Nucleic acids research 23 (4), 628-633, 1995
10051995
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
N Holt, J Wang, K Kim, G Friedman, X Wang, V Taupin, GM Crooks, ...
Nature biotechnology 28 (8), 839-847, 2010
8302010
International AIDS Society global scientific strategy: towards an HIV cure 2016
SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ...
Nature medicine 22 (8), 839-850, 2016
4932016
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
MR Gardner, LM Kattenhorn, HR Kondur, M Von Schaewen, T Dorfman, ...
Nature 519 (7541), 87-91, 2015
3402015
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
J Wang, CM Exline, JJ DeClercq, GN Llewellyn, SB Hayward, PWL Li, ...
Nature biotechnology 33 (12), 1256-1263, 2015
3112015
Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa
M Chen, N Kasahara, DR Keene, L Chan, WK Hoeffler, D Finlay, ...
Nature genetics 32 (4), 670-675, 2002
2912002
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR–Cas9 genome-editing efficiency
MD Canny, N Moatti, LCK Wan, A Fradet-Turcotte, D Krasner, ...
Nature biotechnology 36 (1), 95-102, 2018
2562018
Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases
L Li, L Krymskaya, J Wang, J Henley, A Rao, LF Cao, CA Tran, ...
Molecular Therapy 21 (6), 1259-1269, 2013
2162013
HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
H Hauser, LA Lopez, SJ Yang, JE Oldenburg, CM Exline, JC Guatelli, ...
Retrovirology 7, 1-16, 2010
2012010
Research priorities for an HIV cure: international AIDS society global scientific strategy 2021
SG Deeks, N Archin, P Cannon, S Collins, RB Jones, MAWP de Jong, ...
Nature medicine 27 (12), 2085-2098, 2021
1972021
Delivery methods and compositions for nuclease-mediated genome engineering
PM Cannon, CM Exline, MC Holmes
US Patent 10,604,771, 2020
1492020
Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors
I Christodoulopoulos, PM Cannon
Journal of Virology 75 (9), 4129-4138, 2001
1472001
Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal
LA Lopez, SJ Yang, H Hauser, CM Exline, KG Haworth, J Oldenburg, ...
Journal of virology 84 (14), 7243-7255, 2010
1452010
Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues
PM Cannon, W Wilson, E Byles, SM Kingsman, AJ Kingsman
Journal of virology 68 (8), 4768-4775, 1994
1451994
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein
MM Januszeski, PM Cannon, D Chen, Y Rozenberg, WF Anderson
Journal of virology 71 (5), 3613-3619, 1997
1401997
New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and-independent entry pathways, and glycoproteins from human pathogenic strains are associated …
ML Flanagan, J Oldenburg, T Reignier, N Holt, GA Hamilton, VK Martin, ...
Journal of virology 82 (2), 938-948, 2008
1332008
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
DL DiGiusto, PM Cannon, MC Holmes, L Li, A Rao, J Wang, G Lee, ...
Molecular therapy Methods & clinical development 3, 2016
1262016
Chemokine receptor 5 knockout strategies
P Cannon, C June
Current Opinion in HIV and AIDS 6 (1), 74-79, 2011
1182011
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17
PM Cannon, S Matthews, N Clark, ED Byles, O Iourin, DJ Hockley, ...
Journal of virology 71 (5), 3474-3483, 1997
1181997
Genome editing technologies: defining a path to clinic: genomic editing: establishing preclinical toxicology standards, bethesda, maryland 10 June 2014
J Corrigan-Curay, M O'reilly, DB Kohn, PM Cannon, G Bao, FD Bushman, ...
Molecular therapy 23 (5), 796-806, 2015
1142015
系统目前无法执行此操作,请稍后再试。
文章 1–20